# European Commission grants conditional approval for Abbott's $25B St. Jude Medical acquisition

The European Commission granted conditional approval for Abbott's $25 billion acquisition of St. Jude Medical, requiring the divestiture of St. Jude's Angio-Seal and Femoseal vascular closure assets and Abbott's Vado steerable sheath, which are already slated for sale to Terumo for $1 billion.

- Type: Acquisition
- Announced: 2016-11-28
- Where: United States
- Value: $25.0B
- Status: announced
- Products: vascular closure devices, steerable sheath
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Terumo](https://endata.com/companies/2811.md) (acquirer)
- [Abbott](https://endata.com/companies/4479.md) (acquirer)
- [St. Jude Medical](https://endata.com/companies/20172.md) (target)

## Sources

- [massdevice.com](https://www.massdevice.com/european-anti-trust-regulators-grant-conditional-approval-abbotts-25b-st-jude-medical-buy/), 2016-11-28: "Anti-trust regulators in the European Union last week granted conditional approval for the $25 billion merger of Abbott and St. Jude Medical."
- [abbott.mediaroom.com](https://abbott.mediaroom.com/2017-01-04-Abbott-Completes-the-Acquisition-of-St-Jude-Medical), 2017-01-04: "Abbott announced today it has completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena."
- [massdevice.com](https://www.massdevice.com/abbott-closes-25b-st-jude-buy/), 2017-01-04: "Abbott has a strong track record of successfully integrating dozens of businesses on a global scale and accelerating growth."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.